Cargando…
Detecting the stable point of therapeutic effect of chronic myeloid leukemia based on dynamic network biomarkers
BACKGROUND: Most researches of chronic myeloid leukemia (CML) are currently focused on the treatment methods, while there are relatively few researches on the progress of patients’ condition after drug treatment. Traditional biomarkers of disease can only distinguish normal state from disease state,...
Autores principales: | Xu, Junhua, Wu, Min, Zhu, Shanshan, Lei, Jinzhi, Gao, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509869/ https://www.ncbi.nlm.nih.gov/pubmed/31074387 http://dx.doi.org/10.1186/s12859-019-2738-0 |
Ejemplares similares
-
Detecting Early Warning Signal of Influenza A Disease Using Sample-Specific Dynamical Network Biomarkers
por: Zhu, Shanshan, et al.
Publicado: (2018) -
Stem Cell Biomarkers in Chronic Myeloid Leukemia
por: Jiang, Xiaoyan, et al.
Publicado: (2008) -
Therapeutic use of Aldara™ in chronic myeloid leukemia
por: Marleau, Annette M, et al.
Publicado: (2007) -
Chronic Myeloid Leukemia and Cesarean Section: The Anesthesiologist's Point of View
por: Rebahi, Houssam, et al.
Publicado: (2018) -
Genomic Abnormalities as Biomarkers and Therapeutic Targets in Acute Myeloid Leukemia
por: Ribeiro, Sara, et al.
Publicado: (2021)